117977-21-6
117977-21-6
Chemical Structure
Rabeprazole Sulfide
- CAS No.: 117977-21-6
- Formula:C18H21N3O2S
- Molecular Weight:343.45
IUPAC Name: 2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
InChIKey: BSXAHDOWMOSVAP-UHFFFAOYSA-N
SMILES: CC1=C(OCCCOC)C=CN=C1CSC2=NC3=CC=CC=C3N2
Biological Activity: Rabeprazole Sulfide is a sulfide metabolite of Rabeprazole (HY-B0656). Rabeprazole Sulfide inhibits Helicobacter pylori motility. Rabeprazole Sulfide can be used for the research of Helicobacter pylori infection[1][2].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Rabeprazole Sulfide | 99.26% | Rabeprazole Sulfide is a sulfide metabolite of Rabeprazole (HY-B0656). Rabeprazole Sulfide inhibits Helicobacter pylori motility. Rabeprazole Sulfide can be used for the research of Helicobacter pylori infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rabeprazole Sulfide (Standard) | ≥98% | Rabeprazole Sulfide (Standard) is the analytical standard of Rabeprazole Sulfide (HY-W003467). This product is intended for research and analytical applications. Rabeprazole Sulfide is a sulfide metabolite of Rabeprazole (HY-B0656). Rabeprazole Sulfide inhibits Helicobacter pylori motility. Rabeprazole Sulfide can be used for the research of Helicobacter pylori infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rabeprazole sulfide-d3 | Rabeprazole sulfide-d3 is the deuterium labeled Rabeprazole Sulfide (HY-W003467). Rabeprazole Sulfide is a sulfide metabolite of Rabeprazole (HY-B0656). Rabeprazole Sulfide inhibits Helicobacter pylori motility. Rabeprazole Sulfide can be used for the research of Helicobacter pylori infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rabeprazole sulfide-d4 | Rabeprazole sulfide-d4 is the deuterium labeled Rabeprazole Sulfide (HY-W003467). Rabeprazole Sulfide is an active metabolite of Rabeprazole. Rabeprazole is a proton pump inhibitor that suppresses gastric acid secretion through an interaction with (H+/K+)-ATPase in gastric parietal cells. Rabeprazole markedly inhibits the motility of H. pylori. Rabeprazole has the potential for various peptic diseases treatment. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
